Adams, Mary

Banks, Carys

Jones, Aled

Kelly, Daniel

Maben, Jill

Mannion, Russell

English

Adams, Mary

Kelly, Daniel

MABEN, JILL

Mannion, Russell

BANKS, CARYS

Jones, Aled

University of Surrey

BMJLicence to BMJ Publishing Group Limited (“BMJ Group”) for PublicationTo be agreed to by the corresponding author or guarantor on behalf of all authors ("Corresponding Author"). All authors collectively are referred to as the “Contributors”In consideration of the BMJ Group (“the Publishers”) considering to publish the article contained within the original manuscript which includes without limitation any diagrams, photographs, other illustrative material, video, film or any other material howsoever submitted by the Contributor(s) at any time and related to the Contribution (“the Contribution”) in the BMJ (“the Journal”), certain rights are required to be granted by each different category of author(s), which are as follows:1.	For employees of the UK Crown acting in the course of their employment- a non exclusive Licence, as set out below. All provisions of this document apply. The non exclusivity relates to the original submitted manuscript video, films, images, photographs,  diagrams and/or illustrative material only).2.	For employees of the US Federal Government employees acting in the course of their employment, no copyright exists and the Contribution is in the public domain so no licence is required to be granted. The Author Warranties below apply (excluding 1.iii).3.	For all other authors, an exclusive Licence, as set out below. All provisions of this document apply.NB where a Contribution is a multi authored work, each author’s element of the Contribution will be dealt with in accordance with 1, 2 or 3 above, as applicable.  The LicenceThe Licence granted in accordance with 1 or 3 above is:A worldwide, licence, to the Publishers and its licensees in perpetuity (subject to the Reversion of Rights set out below), in all forms, formats and media (whether known now or created in the future), to i) publish, reproduce, distribute, display and store the Contribution, ii) translate the  Contribution  into other languages, create adaptations, reprints, include within collections and create  summaries, extracts and/or, abstracts of the Contribution and convert or allow conversion into any format including without limitation audio, iii) create any other derivative work(s) based in whole or part on the Contribution, iv) to exploit all subsidiary rights that currently exist or as may exist in the future in the Contribution, v) the inclusion of electronic links from the Contribution to third party material where-ever it may be located; and, vi) licence any third party to do any or all of the above.   If you and/or any co-author’s employer owns the copyright to your contribution you must obtain in writing the relevant employers’ consent to grant the licence and agree to all obligations herein. The author(s) hereby agree that in the event that the BMJ Group sell, the whole or part of its journal business to any third party, the benefit and the burden of the Licence contained herein shall be assigned to that third party.Additional Rights and Obligations The author(s) (and their employers as applicable), hereby authorise the Publishers to take such steps as they consider necessary at their own expense in the copyright owners name and on their behalf, if they believe that a third party is infringing or is likely to infringe copyright or the rights granted to the Publishers herein in the Contribution without further recourse to the copyright owner(s). For Original Research articles and Open Access Funded Articles (as both defined below), the Publishers expressly agree to place the published Contribution for display on PubMed Central (including its international mirror sites) promptly without charge to the authors or their employers (provided Pubmed Central does not charge the Publishers), which will include any Publishers’ supplied amendments or retractions.“Original Research” means an article reporting a research study, with a research structured abstract and normally appearing in the Research section of the BMJ.  “Open Access Funded Articles”  means articles funded in whole or part by a research grant from a government and/or charitable organisation(s) that requires open access deposit in PubMed Central. Such articles are identified by the reference to  a Creative Commons  licence.The author(s) acknowledge and accept that BMJ Group may make additional changes to the contribution as considered necessary in accordance with standard editorial processes whether before or after publication.  The Corresponding Author will usually see proofs for their Contribution s and every effort will be made to consult with the Corresponding Author if substantial alterations are made. The BMJ Group may also retract or publish a correction or other notice when it considers this appropriate for legal or editorial reasons and this shall be at its absolute discretion which shall be exercised reasonably.Reversion of RightsIf the Contribution is not published in either the print or electronic versions of the Journal or any other Publisher(s) products, within 12 months of final acceptance by the BMJ Group, (or as otherwise agreed), any Licence granted herein shall automatically terminate and all rights shall revert to the copyright owner. The Publishers may keep a copy of the Contribution as a record (including via any contractor).Rights Granted to Owners of the ContributionOwnership of copyright remains with the author(s) or their employers. All rights not expressly granted are, subject to the Licence terms, reserved by the Publishers. In return for the grant of the Licence herein, the copyright owner(s) shall have the following rights for non-Commercial Use (unless otherwise stated) of the Contribution:  1.The right to reproduce a reasonable number (no more than 100)  print copies of the final Contribution, by copying or downloading from the BMJ Group website, for personal use and to send copies to colleagues in print or electronic form provided no fee is charged and this is not done on a systematic basis ( which includes via mass e-mailings). 2. The right to include the Contribution in a compilation for classroom use (course packs) to be distributed free of charge (other than for  direct photocopying cost) to students at the Contributor(s)’s institution or to be stored in digital format in data rooms for access by students  as part of their course work and for in house training programmes of the Contributor(s)’s employer or at seminars or conferences subject to a limit of 100 copies per conference or seminar. 3. For all articles  (excluding articles commissioned by the Publishers), the right to post a  version of  the final published version of the Contribution, or any abstract of the final published Contribution on the Contributor(s)’s own and/or  his/her  institution’s website after the Publisher’s publication.4. For all Publisher commissioned articles, the right to post a  version of  the final published version of the Contribution, or any abstract of the final published Contribution on the Contributor(s)’s own and/or  his/her  institution’s website 12 months after publication.5. The following statement must accompany the articles posted on the Contributor(s)’s and/or his/her institution’s website: “This article has been published in the BMJ [insert  full citation reference] and can also be viewed on the journal’s website at  www.bmj.com (​http:​\/​​\/​www.bmj..com​)“6. In addition, for Original Research  articles and Open Access Funded Articles copyright owners (and the Publishers) may and may allow third parties to use the Contribution in accordance one of the following Creative Commons licences depending on the source of the research funding as per below:a) where the Original Research  article and/or Open Access Funded Articles is not funded by the Wellcome Trust or UK Research Council, the artciles may be re-used under the terms of the Creative Commons Attribution-Non Commercial 3.0 Unported (CC BY-NC 3.0) see:http://creativecommons.org/licenses/by-nc/3.0/ (​http:​\/​​\/​creativecommons.org​\/​licenses​\/​by-nc​\/​3.0​\/​​) and http://creativecommons.org/licenses/by-nc/3.0/legalcode (​http:​\/​​\/​creativecommons.org​\/​licenses​\/​by-nc​\/​3.0​\/​legalcode​) or any updated versions as determined by the Publisher from time to time.orb) where the Original Research  article and/or Open Access Funded Articles is funded by the Wellcome Trust or UK Research Council, the Contribution may be re-used under the terms of the Creative Commons Attribution 3.0 Unported Licence (CC BY 3.0) see:http://creativecommons.org/licenses/by/3.0/ (​http:​\/​​\/​creativecommons.org​\/​licenses​\/​by​\/​3.0​\/​​)andhttp://creativecommons.org/licenses/by/3.0/legalcode (​http:​\/​​\/​creativecommons.org​\/​licenses​\/​by​\/​3.0​\/​legalcode​)or any updated versions as determined by the Publisher from time to timesubject to ensuring the Publishers and the Journal are referenced (including a full citation) as set out above;  all third  party rights within  all images, diagrams, photograph, other illustrative material or films, not owned by the authors or BMJ Group are cleared independently and  appropriately; and all the Publishers trademarks are removed from any  derivative works and ensuring any translations, for which a prior translation agreement with BMJ Group has not been established, must prominently display the statement: “This is an unofficial translation of an article that appeared in a BMJ Group publication. BMJ Group has not endorsed this translation”.7. The right to publish with the necessary acknowledgement of the Publishers and the Journal, all or part of the material from the published Contribution in a book, essay, position paper, or other non peer reviewed publication authored or edited by the Contributor(s)’s (which may be a  Commercial Use). This does not apply to multiple Contributions in the same journal, for which permission from the Publishers must be sought.8. The right to use selected figures and tables and (of which the author or his employer owns or has licensed) and selected text (up to 300 words) from the Contribution for incorporation within another work published in print or digital format by a third party, so long as full credit is given to the Publishers and use of the parts of the Contribution  is non Commercial Use.9. Subject to it not being contrary to English law to do so (such as for example where the UK has trading or other bans with the country of the Corresponding Authors origin or certain groups of people within), the right to receive a royalty for up to 5 years from publication of 10% of any net receipts less sales commission on single orders in excess of £2000 received by the Publisher for any single Contribution reprint or translation sales to a single third party, subject however to any fee being determined (if charged) at the absolute discretion of the Publishers as may be altered from time to time. If the Publishers receive such an order for reprint sales of the Contribution, they will contact the Corresponding Author at the address given on the published Contribution to find out to whom payment should be made. Corresponding Authors have the responsibility to ensure that all authors have agreed what should be done with any such royalty payment and to keep the Publisher updated with current contact details.For permission to use materials that are beyond permitted here, visit http://www.bmj.com/about-bmj/resources-readers/permissions“Commercial Use” includes:-	copying or downloading of documents, or linking to such postings, for further redistribution, sale or licensing, for a fee;-	copying, downloading or posting by a site or service that incorporates advertising with such content;-	the inclusion or incorporation of document content in other works or services (other than for legally permitted  quotations with an appropriate citation) that is then available for sale or licensing, for a fee.-	use of documents or document content (other than for legally permitted quotations with appropriate citations) by organisations for any promotional or advertising purposes whether direct or indirect, whether for a fee or otherwise.  Distribution by or on behalf of pharmaceutical organisations is considered in all cases as Commercial Use;-	use for the purposes of monetary reward by means of sale, resale, license, loan, hire transfer or other form of commercial exploitation.Author warranties1. The author(s) warrant that: i) they are the sole author(s) of the Contribution which is an original work; ii) the whole or a substantial part of the Contribution has not previously been published; iii) they or their employers are the copyright owners of the Contribution; iv) to the best of their knowledge that the Contribution does not contain anything which is libellous, illegal or infringes any third party’s copyright or other rights; v) that they have obtained all necessary written consents for any patient information which is supplied with the Contribution and vi) that they have declared or will accurately declare all competing interests to the Publisher.Anti BriberyAs a service provider to the BMJ Group, you agree that you shall: (a)comply with all applicable laws, statutes, regulations and codes relating to anti-bribery and anti-corruption including but not limited to the Bribery Act 2010 (Relevant Requirements); b) not engage in any activity, practice or conduct which would constitute an offence under sections 1, 2 or  6 of the Bribery Act 2010 (as amended) if such activity, practice or conduct had been carried out in the UK; (c) comply with any Publisher Ethics and Anti-bribery Policy supplied to you from time to time including as contained as follows (Relevant Policies):http://group.bmj.com/group/about/corporate/Anti-Bribery%20and%20Corruption%20Policy%20-August%202012.pdf (​http:​\/​​\/​group.bmj.com​\/​group​\/​about​\/​corporate​\/​Anti-Bribery%20and%20Corruption%20Policy%20-August%202012.pdf​); (d) promptly report to the Chief Executive Officer or Chairman of the Publisher any request or demand for any undue financial or other advantage of any kind received by you in connection with the performance of this Agreement; Breach of this Clause shall be deemed a material breach of this Agreement.Law and JurisdictionTo the fullest extent permitted by law, this Agreement will be governed by the laws of England and shall be governed and construed in accordance with the laws of England whose courts shall have exclusive jurisdiction, unless as at the date of formation of this Agreement either i) an English judgement could not be enforced in the Corresponding Author’s stated country location; or ii) it would take six months or more for the BMJ Group to enforce an English judgement in the Corresponding Author’s stated country location, then it is hereby agreed that this Agreement shall be governed by the laws of the Corresponding Author’s stated country (or state if applicable) and their courts shall have jurisdiction. Notwithstanding any of the above, this clause is governed by the laws of England.The following statement must be included in your manuscript, together with the relevant tick box line below: “I [insert full  name] The Corresponding Author of this article contained within the original manuscript which includes any diagrams & photographs within and any related or stand alone film submitted  (the Contribution”) has the right to grant on behalf of all authors and does grant on behalf of all authors, a licence to the BMJ Publishing Group Ltd and its licencees, to permit this Contribution (if accepted) to be published in the BMJ and any other BMJ Group products and to exploit all subsidiary rights, as set out in our licence set out at: http://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/copyright-open-access-and-permission-reuse.” IF YOU ARE A  NATIONAL INSTITUTE OF HEALTH (“NIH”) EMPLOYEE, CONTRACTOR OR TRAINEE the following cover sheet will be accepted by the BMJ Group and NIH and incorporated into the above Licence.Please tick one or more boxes as appropriate:	I am the sole author of the Contribution.	I am one author signing on behalf of all co-owners of the Contribution.	The Contribution has been made in the course of my employment and I am signing as authorised by my employer.	I am a US Federal Government employee acting in the course of my employment.	I am not a US Federal Government employee, but some or all of my co-authors are.	I am an employee of the UK Crown* acting in the course of my employment	I am a US Federal Government employee acting in the course of my employment.	I am not a US Federal Government employee, but some or all of my co-authors are.	I am an employee of the UK Crown acting in the course of my employment	I am not an employee of the UK Crown acting in the course of my employment but some/all of my co-authors are.**Such authors should consult guidance and if necessary return any completed form.BMJ Author Licence v  26 March 2013

How do “heroes” speak up? NHS staff raising concerns during covid-19

Online Research @ Cardiff

How Do ‘Heroes’ Speak Up?  NHS Staff Raising Concerns During Covid-19.   In the extraordinary months since Covid-19, NHS healthcare professionals have found themselves in a surreal situation, straddling two distinct realities.  On the one hand, there is such enormous gratitude for their exceptional work from the public and politicians, that they have become the heroes in the frontline of our national fight against the virus.  On the other hand, some have reported cases of workplace bullying, retaliation or threats of disciplinary action when raising legitimate concerns over access to crucial and reliable personal resources, like personal protective equipment (PPE), for their own and their patients’ safety.   NHS workers’ unflinching commitment to the care of patients and colleagues during the pandemic surely needs recognition, as does their development of new ways of working at speed and scale.  However, the depiction of their work as ‘heroic’ diminishes the acceptability of healthcare workers’ petitions to employers for suitable working conditions, environments and adequate equipment [1].  Heroes do not tend to remind their enraptured followers of the human and necessary limits to their endeavours. Heroes do not often point out that their work was done on the basis of equitable returns or entitlements.  Heroes overcome fear and vulnerability. However, recent public expressions of appreciation of healthcare professionals also rests on the identification of actual people with distinct and memorable life stories and regional or ethnic identities.  The public’s desire to know more about the personal histories and experiences of healthcare workers offers a window of opportunity for front-line staff to revise the foundations of a longer conversation within the NHS over if, when and by who their workplace concerns can be heard and acted on.     These new possibilities are open because collective social trust, now called for to manage public fear and uncertainty, is directed towards an NHS that is seen to be made up of various groups and organisations.   Public trust may lean towards the competence and integrity of the NHS – with its various organisational fractions and responsibilities -  but there seems to be a reinvigorated confidence in the integrity and courage of people working at the ‘sharp-end’ of provider organisations.  Perhaps there is a new possibility for trust in both.   While some healthcare employees are silent about workplace concerns [2], institutional silencing of, or ‘deafness’ towards, healthcare staff who raise concerns over concerns with their own and patients’ safety, has been a feature of NHS workplaces for decades [3].   In the UK, there is legislation that directs healthcare professionals to speak up and promises to protect them from detriment, research shows that raising concerns depends more on informal workplace norms and influences rather than on formal policies and procedures [4]. As the Covid-19 situation unfolds, the importance of staff in raising safety concerns, and of organisations to listen, has been noted by NHS inspectors [5].  However, in some NHS Trusts and services, commitment to the local Freedom to Speak Up Guardian’s (FTSUG) work, and the value of hearing staff concerns seems perfunctory. There is no time for the local FTSUG to do more than respond to individual cases of bullying or harassment and no capacity for them to leverage organisational or public concerns about staff and patient safety issues [6].   The regular reporting via the media / social media of staff raising concerns to their employers over the inadequacy of safety equipment or environments of care, and of being threatened or punished for this, show that some healthcare professionals have become confident in finding a public voice when their NHS employer ignores them.  Securing a hearing through media outlets may be quicker and less risky to job situations and relationships than finding a FTSUG or a senior manager to deal with a concern. To raise concerns with FTSUGs or managers, you have to have trust in the people you speak to and confidence in the systems they work in.  Staff and patient safety managers also need courage to act on concerns that can unsettle their colleagues because they redirect of resources and organisational priorities [7].   In all, the COVID crisis has laid bare the question for healthcare professionals over how – and to what effect- they can raise concerns for themselves and their patients.  They might appeal to an attentive public through various media outlets and commentaries or they might still seek out those organisational managers or FTSUGs who will act on their petitions.   The pandemic has also shown us that public trust in organisations cannot be assumed, it has to be earned [8].  If public confidence in the management of NHS organisations is to be earned, NHS managers and the still relatively new FTSUGs have a critical role to play in working together to demonstrate that the workplace concerns of staff are being acted on, and that a longer conversation about raising staff and patient safety concerns becomes possible.   Mary Adams is Senior Research Fellow in the Department of Women and Children’s Health, Faculty of Life Sciences and Medicine, King’s College London.   Daniel Kelly is Royal College of Nursing Chair of Nursing Research, School of Healthcare Sciences, Cardiff University   Jill Maben is Professor of Health Services Research and Nursing and leads the Workforce Organisation and Wellbeing (WOW) theme in the School of Health Sciences at the University of Surrey   Russell Mannion is Professor of Health Systems at the University of Birmingham.   Carys Banks is Research Fellow, School of Health Sciences, University of Surrey.   Aled Jones is Professor of Patient Safety and Healthcare Quality, School of Healthcare Sciences, University of Cardiff and Lead Investigator of the ongoing NIHR Evaluation of the implementation of Freedom to Speak Up Guardians in NHS England.  Twitter:  @maryluadams @profdkelly @AledJonze @workforcepolicy Competing Interests:  None declared by all of the above authors  References 1. Cox CL. 2020 ‘Healthcare Heroes’: problems with media focus on heroism from healthcare workers during the COVID-19 pandemic. Journal of Medical Ethics. Jun 16. 2. https://blogs.bmj.com/bmj/2020/06/23/covid-19-and-the-problem-of-employee-silence-in-healthcare/ 3. Jones A, Kelly D Deafening silence? Time to reconsider whether organisations are silent or deaf when things go wrong BMJ Quality & Safety 2014;23:709-713 4. Mannion, R. and Davies, H., 2019. Raising and responding to frontline concerns in healthcare. Bmj, 366, p.l4944. 5. https://www.cqc.org.uk/news/stories/safety-speaking-during-covid-19-emergency 6. Jones A, Blake J, Banks C, Adams M, Kelly D, Mannion R and Maben J (in press) Speaking up about bullying and harassment in healthcare: reflections and analysis of worker well-being and patient safety following the introduction of an innovative new role in NHS England. In Montgomery A et al. Connecting Health care worker well-being, patient safety and organisational change: The Triple Challenge. Springer Publishing 7. Mannion, R., Davies, H., Millar, R. and Freeman, T., 2018. Board governance for better, safer healthcare. In Global Patient Safety (pp. 43-57). Routledge. 8. Calnan M., S.J. Williams & J. Gabe 2020 Uncertain Times: trust matters during the pandemic. Social Discovery June 2020.  

University of Birmingham Research Portal

https://orca.cardiff.ac.uk/id/eprint/135212/3/How%2BDo%2B%20Heroes%20%2BSpeak%2BUp%2BBMJOpinion.pdf

How do “heroes” speak up? NHS staff raising concerns during covid-19

Abstract

Similar works

Full text

Available Versions

University of Surrey

Online Research @ Cardiff

University of Birmingham Research Portal

University of Birmingham Research Portal